Xenon Pharmaceuticals Inc (XENE) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for XENE. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| FMR | 9,647,998 | $582M | DECREASED |
| BlackRock | 7,522,482 | $454M | INCREASED |
| Avoro Capital Advisors | 5,777,777 | $349M | UNCHANGED |
| T. Rowe Price | 5,416,800 | $327M | INCREASED |
| Polar Capital Holdings | 4,570,556 | $276M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Dawn Svoronos (Director) | EXERCISE | 5,144 | $42K | 2026-09-01 |
| Christopher John Kenney (Chief Medical Officer) | SELL | 700 | $43K | 2026-08-28 |
| Christopher John Kenney (Chief Medical Officer) | SELL | 6,368 | $383K | 2026-08-28 |
| Steven Gannon (Director) | SELL | 10,000 | $641K | 2026-08-11 |
Full institutional holdings, insider history, and congressional trades for Xenon Pharmaceuticals Inc on SentiSense.